Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Kadant Inc, 3 years.
Kadant Inc
Director
Tecogen Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Tecogen Inc. June 5, 202689.3%
-
Tecogen Inc. June 10, 202597.3%
-
Tecogen Inc. June 6, 202495.5%
-
Tecogen Inc. June 8, 202398.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 3, 2026 | Kadant Inc | Option exercise | +128 | — | — |
| Jul 4, 2026 | Kadant Inc | Option exercise | +128 | — | — |
| Apr 4, 2026 | Kadant Inc | Option exercise | +129 | — | — |
| Jan 3, 2026 | Kadant Inc | Option exercise | +131 | — | — |
| Sep 27, 2025 | Kadant Inc | Option exercise | +132 | — | — |
| Jun 1, 2025 | Kadant Inc | Option exercise | +264 | — | — |
| Dec 28, 2024 | Kadant Inc | Option exercise | +151 | — | — |
| Sep 28, 2024 | Kadant Inc | Option exercise | +152 | — | — |
| Aug 26, 2024 | Kadant Inc | Open-market sale | −250 | $321.57 | $80,393 |
| Jun 1, 2024 | Kadant Inc | Option exercise | +303 | — | — |
| Dec 30, 2023 | Kadant Inc | Option exercise | +217 | — | — |
| Sep 30, 2023 | Kadant Inc | Option exercise | +217 | — | — |
| Sep 7, 2023 | Kadant Inc | Open-market sale | −1,200 | $219.79 | $263,748 |
| Jun 1, 2023 | Kadant Inc | Option exercise | +434 | — | — |
| Dec 31, 2022 | Kadant Inc | Option exercise | +235 | — | — |
Questions about John M. Albertine
What boards is John M. Albertine on?
John M. Albertine sits on the boards of Kadant Inc and Tecogen Inc.
How long has John M. Albertine served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.